Valentine Capital Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Valentine Capital Asset Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$4.39M	Sell	28,431 -5,265	-16%	-$769K	4.91%	1
2015 Q3	$4.82M	Sell	33,696 -9,647	-22%	-$1.35M	4.25%	1
2015 Q2	$6.23M	Sell	43,343 -32,680	-43%	-$4.66M	4.19%	1
2015 Q1	$10.7M	Sell	76,023 -18,185	-19%	-$2.8M	3.13%	2
2014 Q4	$14M	Sell	94,208 -38,942	-29%	-$5.72M	3.39%	1
2014 Q3	$20.5M	Sell	133,150 -8,120	-6%	-$1.22M	7.9%	1
2014 Q2	$19.8M	Sell	141,270 -9,265	-6%	-$1.03M	3.81%	2
2014 Q1	$16.7M	Buy	150,535 +5,482	+4%	+$597K	3.47%	2
2013 Q4	$14.3M	Sell	145,053 -3,878	-3%	-$336K	3.07%	2
2013 Q3	$11.3M	Buy	148,931 +2,031	+1%	+$132K	2.96%	4
2013 Q2	$8.21M	Buy	+146,900	New	+$8.68M	2.57%	8

Other funds holding TARO

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

GCM

Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return

AIM

Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return

Valentine Capital Asset Management's TARO Position: Q4 2015 in Review

Valentine Capital Asset Management reduced its Taro Pharmaceutical Industries Ltd. (TARO) stake by 16% in Q4 2015, selling an estimated $769K and leaving 28,431 shares worth $4.39M. The position accounts for 4.91% of the portfolio, ranked #1.

Valentine Capital Asset Management first reported a position in TARO in Q2 2013 and has held it in 11 quarters since. The position peaked at $20.5M in Q3 2014. 153 funds tracked by Wall St. Rank hold TARO as of Q4 2015.

Valentine Capital Asset Management held 28,431 shares of Taro Pharmaceutical Industries Ltd. worth $4.39M as of Q4 2015.
Valentine Capital Asset Management sold 5,265 Taro Pharmaceutical Industries Ltd. shares in Q4 2015, an estimated $769K.
Taro Pharmaceutical Industries Ltd. made up 4.91% of Valentine Capital Asset Management's portfolio in Q4 2015, its #1 holding.
Valentine Capital Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and has held it in 11 quarters since.
Valentine Capital Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $20.5M in Q3 2014.
153 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2015.

Based on Valentine Capital Asset Management's 13F filing for Q4 2015, filed 17 Feb 2016.